-
srdr.ahrq.gov/projects/1542/studies/186813
January 01, 2018 - Opioid-containing Analgesics: Codeine
24 hours
N Analyzed
34 … Opioid-containing Analgesics: Codeine
24 hours
N Analyzed
34 … Opioid-containing Analgesics: Codeine
0 N/A
N Analyzed
34 … Opioid-containing Analgesics: Codeine
0 N/A
N Analyzed
34 … Opioid-containing Analgesics: Codeine
24 hours
N Analyzed
34
-
srdr.ahrq.gov/projects/1565/studies/188323
January 01, 2016 - Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … Point
Measure
CPAP
No CPAP
Enter a numeric value or title (required) years
N Analyzed … 5.5
SD
1.9
1 years
N Analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1_0.xlsx
November 22, 2021 - Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186139
January 01, 2010 - Antibiotic: Ertapenem
1 years
N Analyzed
39
49
P-Value
N.S … Antibiotic: Ertapenem
1 years
N Analyzed
40
48
P-Value
N.S … Antibiotic: Ertapenem
1 years
N Analyzed
40
48
P-Value
N.S … Antibiotic: Ertapenem
1 years
N Analyzed
43
48
P-Value
N.S … Antibiotic: Ertapenem
1 years
N Analyzed
43
48
P-Value
N.S
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186797
January 15, 2021 - Participants
Time Point
Measure
Elective surgery
Elective surgery
Elective surgery
30 days
N Analyzed … Elective surgery
Elective surgery
Elective surgery
Enter a numeric value or title (required) years
N Analyzed … Elective surgery
Elective surgery
Elective surgery
Enter a numeric value or title (required) years
N Analyzed … Elective surgery
Elective surgery
Elective surgery
Enter a numeric value or title (required) years
N Analyzed … Elective surgery
Elective surgery
Elective surgery
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188518
January 01, 2016 - All Participants
Time Point
Measure
CPAP
No CPAP
>=2 and <=7 years
N Analyzed … Population: PCI
Time Point
Measure
CPAP
No CPAP
>=2 and <=7 years
N Analyzed … All Participants
Time Point
Measure
CPAP
No CPAP
>=2 and <=7 years
N Analyzed … Population: PCI
Time Point
Measure
CPAP
No CPAP
>=2 and <=7 years
N Analyzed … All Participants
Time Point
Measure
CPAP
No CPAP
>=2 and <=7 years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186827
January 01, 2017 - Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Hinchey Ia
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Hinchey ≥Ib
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Hinchey Ia
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Hinchey ≥Ib
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186841
January 01, 2014 - Healthy controls
Enter a numeric value or title (required) years
N Analyzed
149 … Healthy controls
Diverticulitis without colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Healthy controls
Diverticulitis without colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Healthy controls
Enter a numeric value or title (required) years
N Analyzed
149 … Healthy controls
Enter a numeric value or title (required) years
N Analyzed
149
-
srdr.ahrq.gov/projects/1520/studies/186839
January 01, 2019 - Antibiotics: Multiple (discretionary or undefined)
30 days
N Analyzed
18
18 … Antibiotics: Multiple (discretionary or undefined)
30 days
N Analyzed
18
18 … Antibiotics: Multiple (discretionary or undefined)
30 days
N Analyzed
12
12 … IR: Percutaneous drainage
30 days
N Analyzed
12
12
P-Value … Antibiotics: Multiple (discretionary or undefined)
During initial admission N/A
N Analyzed
18
-
srdr.ahrq.gov/projects/1312/studies/175439
January 01, 2003 - Comments ( 0 ) |
Post/View
n Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 12
8
SE
4 weeks
N Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 weeks
N Analyzed … 13
9
SE
4 weeks
N Analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - Trial Type
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - Trial Type
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed … Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/189001
January 01, 2016 - No CPAP
6 months
N Analyzed
151
147 … No CPAP
6 months
N Analyzed
151
147 … No CPAP
6 months
N Analyzed
151
147 … No CPAP
6 months
N Analyzed
151
147 … No CPAP
6 months
N Analyzed
151
147
-
srdr.ahrq.gov/projects/1542/studies/186850
January 01, 1995 - Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation
Baseline N/A
N Analyzed … Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation
Baseline N/A
N Analyzed … Therapies: Thermal biofeedback, and Behavioral therapies: Relaxation
Baseline N/A
N Analyzed … 0.45
SD
0.77
Perinatal N/A
N Analyzed … Mean
0.45
SD
3 months postnatal N/A
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186820
January 01, 2016 - )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … )
Population: All Participants
Time Point
Measure
Elective surgery
30 days
N Analyzed … (CD III)
Population: BMI 30-35
Time Point
Measure
Elective surgery
30 days
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/189216
January 01, 2013 - Point
Measure
Placebo
Pharm: 5-ASA
Pharm: Mesalamine + Probiotic
Comparison Measure
12 weeks
N Analyzed … 5
4.248
Percentage
20
12.5
11.8
52 weeks
N Analyzed … Participants
Time Point
Measure
Placebo
Pharm: 5-ASA
Pharm: Mesalamine + Probiotic
12 weeks
N Analyzed … Placebo
52 weeks
N Analyzed
29
32
27
P-Value … ERROR
52 weeks
N Analyzed
29
32
27
P-Value
NS
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
January 01, 2025 - for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed … for Between Group Mean ∆ Intervention B, N Analyzed for Between Group Mean ∆ Intervention C, N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188958
January 01, 2012 - Population: All Participants
Time Point
Measure
No CPAP
CPAP
4 years
N Analyzed … Population: All Participants
Time Point
Measure
No CPAP
CPAP
4 years
N Analyzed … Population: All Participants
Time Point
Measure
No CPAP
CPAP
4 years
N Analyzed … No CPAP
4 years
N Analyzed
366
357 … No CPAP
4 years
N Analyzed
3
8
Incidence
-
srdr.ahrq.gov/projects/1520/studies/186816
January 01, 2002 - Pharm: Rifaximin
3 months
N Analyzed
109
109
P-Value
<0.005 … Counts
42
19
Percentage
38.53
17.43
6 months
N Analyzed … Pharm: Rifaximin
12 months
N Analyzed
109
109
P-Value
<0.01 … Pharm: Rifaximin
3 months
N Analyzed
109
109
P-Value
<0.005 … All Participants
Time Point
Measure
Pharm: 5-ASA + Rifaximin
Pharm: Rifaximin
12 months
N Analyzed